Medical Weight Loss for Revere, Massachusetts Residents

Revere, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Revere through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Revere? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in Massachusetts. Doctor review just $119 (medication separate).

Why Revere Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Revere a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Massachusetts. That is the entire promise, and we keep it.

Revere is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

There is no New Hope Weight Loss office in Revere, and there does not need to be, since the same doctor-led program is delivered to every corner of Massachusetts through telehealth visits. We care for patients throughout Revere Beach and the inner Boston metro area of Suffolk County. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Revere.

Most people across Revere do not wait for an opening, they pick a time, meet Dr. Sharma by video, and can begin treatment within days. If you would rather spread payments out, Revere patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Revere choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Revere

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Revere. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Revere address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Revere

Where is the closest New Hope Weight Loss to Revere?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Revere, Massachusetts patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Revere?

It is not. We run a complete telehealth model, so people in Revere handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Revere using cold-pack insulation that keeps it stable until it reaches you.

What should a Revere patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Revere patients are not charged any extra distance fee.

What areas of Revere do you serve?

We serve patients from across Revere by telehealth, including Revere Beach and the inner Boston metro area of Suffolk County.

Is bilingual (Spanish) telehealth care available for Revere patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Revere patients.

Revere Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Revere, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.